BN

Babita Negi

Active Director Director DIN 05278200
DIN 05278200 First appointment Jun 2012 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2012
Shareholding value •••• Premium profile

About Babita Negi

Data last updated:

Babita Negi is a Director at Br Biochem Life Sciences Private Limited (since 2012). The company operates in Healthcare. Br Biochem Life Sciences Private Limited reported revenue of ₹14.57 Cr (FY 2025).

DIN 05278200
Primary Designation Director
Industry Healthcare
First Appointment 13 Jun 2012
Oldest Company Age 14 yrs
Largest company Br Biochem Life Sciences Private Limited · ₹14.57 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director13 Jun 20122012₹14.57 Cr (FY 2025)Active

Board colleagues of Babita Negi

NameDINCompanyDesignation
Rakesh Singh05278202Br Biochem Life Sciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Br Biochem Life Sciences Private Limited
Premium access

Shareholding and investment profile for Babita Negi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Babita Negi

Babita Negi currently holds 1 directorship: Br Biochem Life Sciences Private Limited (Director, since 13 Jun 2012, revenue ₹14.57 Cr (FY 2025)).

Babita Negi was first appointed on 13 Jun 2012 as Director at Br Biochem Life Sciences Private Limited.

The current boards of Babita Negi's companies include Rakesh Singh (Br Biochem Life Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available